Page last updated: 2024-08-21

nitrosobenzylmethylamine and Esophageal Squamous Cell Carcinoma

nitrosobenzylmethylamine has been researched along with Esophageal Squamous Cell Carcinoma in 4 studies

*Esophageal Squamous Cell Carcinoma: A carcinoma that originates usually from cells on the surface of the middle and lower third of the ESOPHAGUS. Tumor cells exhibit typical squamous morphology and form large polypoid lesions. Mutations in RNF6, LZTS1, TGFBR2, DEC1, and WWOX1 genes are associated with this cancer. [MeSH]

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (50.00)24.3611
2020's2 (50.00)2.80

Authors

AuthorsStudies
Liu, Q; Liu, R; Lu, Q; Pu, Y; Wang, S; Yin, L; Yu, X; Zhang, H; Zhang, Y; Zhao, C; Zhou, J1
Deng, G; Fan, H; Jiang, W; Lu, SH; Yu, X; Zheng, W; Zou, Z1
Deng, X; Fan, H; Guo, L; Jiang, W; Lu, SH; Yu, X; Zhan, Q; Zheng, W; Zou, Z1
Dombkowski, A; Gu, F; Huang, YW; Stoner, GD; Wang, LS1

Other Studies

4 other study(ies) available for nitrosobenzylmethylamine and Esophageal Squamous Cell Carcinoma

ArticleYear
Metabolomic transition trajectory and potential mechanisms of N-nitrosomethylbenzylamine induced esophageal squamous cell carcinoma in rats.
    Ecotoxicology and environmental safety, 2022, Oct-01, Volume: 244

    Topics: Animals; Carcinogens; Carcinogens, Environmental; Cell Transformation, Neoplastic; Dimethylnitrosamine; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Metabolome; NAD; Niacin; Niacinamide; Nitrogen; Nitrosamines; Rats; Sphingolipids; Tryptophan; Tumor Microenvironment

2022
Aspirin enhances the therapeutic efficacy of cisplatin in oesophageal squamous cell carcinoma by inhibition of putative cancer stem cells.
    British journal of cancer, 2021, Volume: 125, Issue:6

    Topics: Animals; Aspirin; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cisplatin; Dimethylnitrosamine; Drug Synergism; Epigenesis, Genetic; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Female; Gene Expression Regulation, Neoplastic; Humans; Male; Mice; Neoplastic Stem Cells; Rats; Xenograft Model Antitumor Assays

2021
Metformin suppresses the esophageal carcinogenesis in rats treated with NMBzA through inhibiting AMPK/mTOR signaling pathway.
    Carcinogenesis, 2019, 07-04, Volume: 40, Issue:5

    Topics: AMP-Activated Protein Kinases; Animals; Carcinogenesis; Carcinogens; Cell Proliferation; Dimethylnitrosamine; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Hypoglycemic Agents; Male; Metformin; Rats; Rats, Inbred F344; TOR Serine-Threonine Kinases; Tumor Cells, Cultured

2019
Black raspberries demethylate Sfrp4, a WNT pathway antagonist, in rat esophageal squamous cell papilloma.
    Molecular carcinogenesis, 2016, Volume: 55, Issue:11

    Topics: Animals; Carcinoma, Squamous Cell; Dimethylnitrosamine; DNA (Cytosine-5-)-Methyltransferase 1; DNA (Cytosine-5-)-Methyltransferases; DNA Methylation; DNA Methyltransferase 3B; Epigenesis, Genetic; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Gene Expression Regulation, Neoplastic; Humans; Male; Plant Extracts; Proto-Oncogene Proteins; Rats; Rubus; Wnt Signaling Pathway

2016